Effectiveness and safety of ranibizumab in patients with central retinal vein occlusion: results from the real-world, global, LUMINOUS study.
- DOI
- 10.1038/s41433-021-01702-y
- Published
- 2022 Aug
- Container
- Eye (London, England)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41433-021-01702-y,
title = {Effectiveness and safety of ranibizumab in patients with central retinal vein occlusion: results from the real-world, global, LUMINOUS study.},
author = {Lotery A and Clemens A and Tuli R and Xu X and Shimura M and Nardi M and Ziemssen F and Dunger-Baldauf C and Tadayoni R and LUMINOUS™ study group},
year = {2022},
journal = {Eye (London, England)},
doi = {10.1038/s41433-021-01702-y},
url = {https://doi.org/10.1038/s41433-021-01702-y}
}RIS
TY - JOUR TI - Effectiveness and safety of ranibizumab in patients with central retinal vein occlusion: results from the real-world, global, LUMINOUS study. AU - Lotery A AU - Clemens A AU - Tuli R AU - Xu X AU - Shimura M AU - Nardi M AU - Ziemssen F AU - Dunger-Baldauf C AU - Tadayoni R AU - LUMINOUS™ study group PY - 2022 JO - Eye (London, England) DO - 10.1038/s41433-021-01702-y UR - https://doi.org/10.1038/s41433-021-01702-y ER -
APA
A, L., A, C., R, T., X, X., M, S., M, N., F, Z., C, D., R, T., & group, L. S. (2022). Effectiveness and safety of ranibizumab in patients with central retinal vein occlusion: results from the real-world, global, LUMINOUS study.. Eye (London, England). https://doi.org/10.1038/s41433-021-01702-y
Source records
- pubmed · retrieved 2026-09-26T15:17:28.896Z